Financial Comparison: Stevanato Group (NYSE:STVN) and Acutus Medical (NASDAQ:AFIB)

Acutus Medical (NASDAQ:AFIB) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Acutus Medical and Stevanato Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acutus Medical	0	0	0	0	0.00
Stevanato Group	0	1	5	0	2.83

Valuation and Earnings

This table compares Acutus Medical and Stevanato Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acutus Medical	$7.16 million	0.19	-$81.66 million	N/A	N/A
Stevanato Group	$1.09 billion	4.95	$157.62 million	€0.47 ($0.49)	38.09

Stevanato Group has higher revenue and earnings than Acutus Medical.

Profitability

This table compares Acutus Medical and Stevanato Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acutus Medical	-272.74%	-311.64%	-11.57%
Stevanato Group	10.47%	9.86%	5.79%

Institutional & Insider Ownership

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 0.7% of Stevanato Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

Acutus Medical has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

Summary

Stevanato Group beats Acutus Medical on 9 of the 11 factors compared between the two stocks.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.